
Glomika 250 Injection
Marketer
Globus Remedies Ltd
Salt Composition
Amikacin (250mg)
Overview Glomika 250 Injection
Avelox 250 Injection, a broad-spectrum antibiotic, combats bacterial infections affecting diverse body systems, such as the urinary tract, musculoskeletal system, respiratory system (including pneumonia), central nervous system, and bloodstream. Prophylactic use is also indicated in hospitalized individuals. Its mechanism involves bacterial growth inhibition. Administered intravenously or intramuscularly by a healthcare professional only, it requires adherence to a prescribed dosage schedule. Complete the entire course, even with symptom improvement; premature cessation risks relapse or infection exacerbation. Potential adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant medical consultation. High-dose therapy may induce vertigo, nephrotoxicity, and ototoxicity, necessitating close monitoring via renal function tests, audiometry, and urinalysis as directed by your physician. Pregnancy contraindicates its use; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Primary Ingredients of Glomika 250 Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Glomika 250 Injection
Infections caused by bacteria
Major Benefits of Glomika 250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Glomika 250 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Glomika 250 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Glomika 250 Injection works:
Glomika 250 Injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Glomika 250 Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Using Glomika 250 Injection during pregnancy poses a confirmed risk to the fetus. Its use should be avoided. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Glomika 250 presents no known breastfeeding contraindications. Research in human subjects indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administering Glomika 250 Injection can lead to reduced awareness, visual disturbances, drowsiness, and vertigo. Driving should be avoided if such effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Glomika 250 Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Glomika 250 Injection appears to be well-tolerated by individuals with hepatic impairment. Available evidence indicates that dose modification for Glomika 250 Injection may be unnecessary in this population. Physician consultation is recommended.
What if you forget to take Glomika 250 Injection :
Omit a Glomika 250 Injection dose? Seek your physician's advice.
Facts to Know About Glomika 250 Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
